Neonc Technologies Holdings, Inc.(NTHI)

Biotechnology · Calabasas, CA

$2.95+0.03 (+1.03%)

Delayed quote: Oct 6, 2026, 3:14 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:17:50.794Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:17:50.794Z.

Quote observation: 2026-10-06T19:14:53.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.95
Unrounded diluted TTM EPS · period ending 2026-06-30: -2.22

FMP input reference: 2d3a9198413857e44d8ff08287218970dc762668c083e85858692cc7a401d48f

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

NTHI PE Ratio Metrics

PE RATIO

N/A

NTHI Competitors' PE Ratio

NTHI

Neonc Technologies Holdings, Inc.

Current

Market Cap

$76.50M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SERA

Sera Prognostics, Inc.

vs NTHI

Market Cap

$77.15M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Outset Medical, Inc.

vs NTHI

Market Cap

$77.51M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTOR

Citius Oncology, Inc.

vs NTHI

Market Cap

$75.50M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INO

Inovio Pharmaceuticals, Inc.

vs NTHI

Market Cap

$78.42M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SKIN

SkinHealth Systems Inc.

vs NTHI

Market Cap

$76.27M

PE Ratio

N/A

TTM Avg

63.47

3Y Avg

35.79

5Y Avg

35.79

LUNG

Pulmonx Corporation

vs NTHI

Market Cap

$75.39M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HYPR

Hyperfine, Inc.

vs NTHI

Market Cap

$75.87M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VTVT

vTv Therapeutics Inc.

vs NTHI

Market Cap

$79.09M

PE Ratio

N/A

TTM Avg

1681.60

3Y Avg

1681.60

5Y Avg

1681.60

ACRV

Acrivon Therapeutics, Inc. Common Stock

vs NTHI

Market Cap

$80.90M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Neonc Technologies Holdings, Inc. (NTHI)	$76.50M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$77.15M	N/A	N/A	N/A	N/A
Outset Medical, Inc. (OM)vs ›	$77.51M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$75.50M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$78.42M	N/A	N/A	N/A	N/A
SkinHealth Systems Inc. (SKIN)vs ›	$76.27M	N/A	63.47	35.79	35.79
Pulmonx Corporation (LUNG)vs ›	$75.39M	N/A	N/A	N/A	N/A
Hyperfine, Inc. (HYPR)vs ›	$75.87M	N/A	N/A	N/A	N/A
vTv Therapeutics Inc. (VTVT)vs ›	$79.09M	N/A	1681.60	1681.60	1681.60
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$80.90M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.95

Forward EPS (Est.)

$-1.39

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

NTHI PE Ratio Metrics

NTHI Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics